A novel DDR1 inhibitor enhances the anticancer activity of gemcitabine in pancreatic cancer.
Ko S, Jung KH, Yoon YC, Han BS, Park MS, Lee YJ, Kim SE, Cho YJ, Lee P, Lim JH, Ryu JK, Kim K, Kim TY, Hong S, Lee SH, Hong SS.
Ko S, et al. Among authors: kim se, kim ty, kim k.
Am J Cancer Res. 2022 Sep 15;12(9):4326-4342. eCollection 2022.
Am J Cancer Res. 2022.
PMID: 36225647
Free PMC article.